Box 61
Contains 33 Results:
Cancer: Senate Cancer Coalition - the March Research Task Force, 1998 September
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Cancer: Tamoxifen - consent, 1992-1994
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Cancer: Tamoxifen - Food and Drug Administration (FDA) testimony, 1994
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Cancer: Tamoxifen - prevention trial, 1994-1995
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Food and Drug Administration (FDA) Modernization Act: Access to experimental perscriptions, 1991
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Food and Drug Administration (FDA) Modernization Act: Off-label bill - American Medical Association (AMA), 1997
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Food and Drug Administration (FDA) Modernization Act: Off-label bill - conference, 1997
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Food and Drug Administration (FDA) Modernization Act: Off-label bill - implimenting regulations, 1998
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Food and Drug Administration (FDA) Modernization Act: Off-label bill - labor committee, 1996
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
Food and Drug Administration (FDA) Modernization Act: Off-label bill - language, 1995-1997
Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.
